In Brief: Possis Medical
This article was originally published in The Gray Sheet
Executive Summary
Possis Medical: Plans "early summer" U.S. clinical trials of its AngioJet thrombectomy system for coronary arteries and bypass grafts at four sites and up to 60 patients under an FDA investigational device exemption. For peripheral applications, at least 53 patients have been enrolled in clinical trials ("The Gray Sheet" Sept. 21, 1992, In Brief)...